Switch Announces CASi-APOE RNAi Therapy, New Advisory Board Member
03 Dec 2024 //
BUSINESSWIRE
Switch Therapeutics to present at Neuro Perspectives Virtual Conference.
25 Jun 2024 //
BUSINESSWIRE
Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
22 Feb 2024 //
BUSINESSWIRE
Switch Therapeutics Appoints Charles Allerson as Chief Technology Officer
03 Jan 2024 //
BUSINESSWIRE
Switch to Present at Morgan Stanley 21st Annual Global Healthcare Conference
06 Sep 2023 //
BUSINESSWIRE
Switch Therapeutics Announces Formation of Scientific Advisory Board
01 Jun 2023 //
BUSINESSWIRE
Switch Therapeutics Expands Leadership Team with Key Appointments
28 Mar 2023 //
BUSINESSWIRE

Market Place
Sourcing Support